MEMPHIS, Tenn.--(BUSINESS WIRE)--MMI-USA, a subsidiary of Memometal Technologies S.A., a global orthopaedic manufacturer headquartered in Bruz, France, announces the launch of MemoDerm™ Acellular Dermal Matrix, a terminally sterilized, single-application onlay graft used to promote healing of diabetic foot ulcers and other soft-tissue repairs. The MemoDerm Acellular Dermal Matrix will be a technology platform for a future family of products.
